<i>FHIT</i> , a Novel Modifier Gene in Pulmonary Arterial Hypertension

Abstract

This study highlights the importance of the novel BMPR2 modifier FHIT in PH and the clinical value of the repurposed drug enzastaurin as a potential novel therapeutic strategy to improve PAH.